Table 1.
Components of innate immunity that recognize a Xenograft.
Immune Response | Component | Rejection Mechanism | Target Gene Editing | Rejection Period |
---|---|---|---|---|
Innate | Complement alternative pathway | Inhibits complement activation | factor H | HAR |
Complement regulatory proteins | Complement regulation | hCD55; hCD46; hCD59 expression | HAR; AVR | |
Natural antibody | Reduces natural anti- αGal and non-Gal antibodies responses | GGTA1-KO; CMAH-KO; β4GALNT2-KO | HAR; AVR | |
Platelet/Thrombin | Coagulation/thrombosis reduction | Human Thrombomodulin; human CD39 expression |
AVR | |
Macrophage | Macrophages regulation | hCD47 expression (a marker for “self”); human signal regulatory protein alpha expression; human heme oxygenase 1 expression; human A20 expression; human CD39 expression. |
AVR | |
NK cell | Natural NK cells regulation | human HLA-G, HLA-E expression; human beta2 microglobulin expression |
AVR | |
Neutrophil | Neutrophils regulation | Integrins | AVR |
Abbreviations: αGal, galactose alpha-1,3-galactose; αGalT-KO, alpha1,3-galactosyltransferase-knockout; MHC: major histocompatibility complex; NK, natural killer; HLA, human leukocyte antigen; hCD47, human CD47; HAR, hyperacute rejection; AVR, acute vascular rejection.